Suchergebnisse - "JAK inhibitor"

PubPharm (162)

1

Target Occupancy and Functional Inhibition of JAK3 and TEC Family Kinases by Ritlecitinib in Healthy Adults : An Open-Label, Phase 1 Study

enthalten in: Journal of clinical pharmacology | 2024

von Martin, D. | Telliez, J. | Pleasic-Williams, S. | +12

2

JAK inhibitor treatment for inborn errors of JAK/STAT signaling : An ESID/EBMT-IEWP retrospective study

enthalten in: The Journal of allergy and clinical immunology | 2024

von Fischer, M. | Olbrich, P. | Hadjadj, J. | +54

3

Anti-synthetase syndrome is associated with a higher risk of hospitalization among patients with idiopathic inflammatory myopathy and COVID-19

enthalten in: Frontiers in immunology | 2024

von Wu, W. | Wang, R. | Xie, C. | +15

4

Management and treatment outcomes of rheumatoid arthritis in the era of biologic and targeted synthetic therapies : evaluation of 10-year data from the KURAMA cohort

enthalten in: Arthritis research & therapy | 2024

von Fujii, T. | Murata, K. | Onizawa, H. | +12

5

The steroid-sparing effect of JAK inhibitors across multiple patient populations

enthalten in: Frontiers in immunology | 2024

von Conigliaro, P. | Minerba, C. | Vendola, A. | +6

6

Topical treatments for atopic dermatitis (eczema) : Systematic review and network meta-analysis of randomized trials

enthalten in: The Journal of allergy and clinical immunology | 2023

von Chu, D. | Chu, A. | Rayner, D. | +37

7

Tissue Engineering of JAK Inhibitor-Loaded Hierarchically Biomimetic Nanostructural Scaffold Targeting Cellular Senescence for Aged Bone Defect Repair and Bone Remolding

enthalten in: Advanced healthcare materials | 2023

von Liu, S. | Jia, X. | Hao, J. | +5

8

Design, synthesis, and pharmacological evaluation of quinazoline derivatives as novel and potent pan-JAK inhibitors

enthalten in: Bioorganic chemistry | 2023

von Xiang, J. | Wang, Y. | Wang, W. | +17

9

Kinase Signaling in Colitis-Associated Colon Cancer and Inflammatory Bowel Disease

enthalten in: Biomolecules | 2023

von Temby, M. | Boye, T. | Hoang, J. | +2

10

A randomized, double-blind, placebo-controlled phase II study to evaluate the efficacy and safety of ivarmacitinib (SHR0302) in adult patients with moderate-to-severe alopecia areata

enthalten in: Journal of the American Academy of Dermatology | 2023

von Zhou, C. | Yang, X. | Yang, B. | +17

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]